Longueuil, Quebec, Canada – MENODYS is proud to announce the launch of the prototyping phase of its tinnitus assessment technology. Invented by Pr Sylvie Hébert and Philippe Fournier of the School of Speech Pathology and Audiology of the University of Montreal, the device will offer audiology specialists around the world an innovative approach to objectively assess the frequency and amplitude of tinnitus.
Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians, 30 million Americans and more than 120 million Europeans.
“ We are excited to launch the development of the Tinnitus Assessment Technology, the third technology in MENODYS’ portfolio, which confirms the acceleration of our business plan of developing and commercializing innovations in the medical device sector” said René Gosselin, President at MENODYS.
MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com